Tower Research Capital LLC (Trc) Ayala Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$8.32 - $12.45 $1,356 - $2,029	-163 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$8.13 - $14.09 $2,495 - $4,325	-307 Reduced 65.32%	163 $2,000
Q2 2021 Aug 16, 2021	SELL	$9.2 - $11.3 $11,702 - $14,373	-1,272 Reduced 73.02%	470 $4,000
Q1 2021 May 17, 2021	BUY	$10.72 - $22.0 $6,110 - $12,540	570 Added 48.63%	1,742 $19,000
Q4 2020 Feb 16, 2021	BUY	$9.67 - $13.5 $11,333 - $15,822	1,172 New	1,172 $13,000
Q3 2020 Nov 16, 2020	SELL	$8.8 - $14.55 $29,946 - $49,513	-3,403 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$10.0 - $15.92 $34,030 - $54,175	3,403 New	3,403 $34,000

Ticker AYLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,833,300
Description
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinic...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.